Alzheimer's Disease: Newly Found Peptide Offers Hope of Early Test and Better Treatment

Researchers in Japan have detected a **peptide** in **cerebrospinal fluid** (CSF) that can show whether a person is developing **Alzheimer's disease**. Measuring the level of this peptide could show that the disease process has started, long before any serious damage is done to the brain. This research, published in the journal EMBO Molecular Medicine, raises **new opportunities** for combating Alzheimer's disease. Currently **treatments** can only be started after considerable structural damage has occurred in the person's brain. However, if this finding is broadly used as a **clinical test**, treatment may be possible before too much damage is present, offering the hope of much better outcomes. "Osaka University":[ http://www.osaka-u.ac.jp/en/news/topics]

---